Navigation Links
Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs
Date:2/11/2010

commercial operations. In addition, the company has a clinical development division in Edison, New Jersey that employs 350 people who oversee clinical trials being conducted around the world.    

Prior to joining DSI, Dr. Feingold worked with Wyeth Pharmaceuticals, where he most recently led Oncology Global Clinical Development.  Prior to that, he was multi-therapeutic area head in Global Medical Affairs with responsibility for the hematology, oncology and central nervous system (CNS) franchises.

Dr. Feingold, a member of the American Society of Hematology and American Society of Clinical Oncology, is a molecular biologist who earned his Bachelor of Science degree from S.U.N.Y. Stony Brook and his Medical Degree, Master of Science and Ph.D. degrees from Albert Einstein College of Medicine.  Dr. Feingold did his residency in Pediatrics and fellowship in Pediatric Hematology/Oncology at the UCLA Center for the Health Sciences.

About Daiichi Sankyo, Inc.

Daiichi Sankyo Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Tokyo-based Daiichi Sankyo Co., Ltd., which is a global pharmaceutical innovator.  The headquarters company was established in 2005 from the merger of two leading Japanese pharmaceutical companies.  This integration created a more robust organization that allows for continuous development of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo's research

and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes and acute coronary syndrome. Also important to the company is the discovery of new medicines in the areas of infectious diseases, cancer, bone and joint diseases, and immune disorders. For mor
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin
2. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
3. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
4. Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
5. Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation
6. YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB
7. KGI Names Kerry Howell Vice President for Advancement
8. Vical Names Andrew de Guttadauro Vice President, Corporate Development
9. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. CryoLife Names Philip Theodore as Vice President, General Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 Biotechnology industry pioneer ... with financial software provider BlackLine Systems  and enterprise ... SAP ) for a webinar next week entitled "No ... from BlackLine and SAP to Help Keep Its Account Reconciliations ... http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, geared at finance, ...
(Date:6/19/2013)... Canada (PRWEB) June 19, 2013 ... trial business can potentially be worth up to ... this opportunity, the Indian government is taking serious ... trials the process. , This presentation will examine:, ... trial regulations ,     Immediate and long term ...
(Date:6/19/2013)... June 19, 2013 Express Diagnostics Int’l, ... today announced that it has received Class III medical ... sell its DrugCheck® NxStep Onsite Drug Screen Cup ... the rapid screening device in near-patient settings, such as ... Cup received Health Canada Class III approval for 24 ...
(Date:6/18/2013)... A million electric cars could be on roads across ... help of research by the United States Department of Energy, ... Professor Zhongwei Chen is part of a team led by ... to replace the expensive platinum catalysts in fuel cells. , ... cells in vehicles is the cost of the units. The ...
Breaking Biology Technology:Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2
... July 14 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), ... agreement to exclusively license seven cancer antigens from ... antigens specifically target breast, ovarian and prostate cancers. ... DepoVax(TM) delivery platform to develop DPX-0907, a therapeutic ...
... , , TAMPA, Fla., July 14 ... the research and development of cancer immunotherapies, announces that the first ... dendritic cell therapy. , , ... clinical trial testing the safety and efficacy of its immunotherapy on ...
... , , ... biotechnology company delivering breakthrough therapies in central nervous system ... the efficacy of the ketogenic compound AC-1202 (Axona(TM)) in ... completed double-blind, placebo-controlled trial in patients with mild-to-moderate Alzheimer,s ...
Cached Biology Technology:ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens 2Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial 2Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial 3Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease 2Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease 3Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease 4
(Date:6/19/2013)... paper published in the journal Polar Biology, researchers report using ... may be a new type of killer whale ( Orcinus ... unusual-looking killer whales stranded on a New Zealand beach and ... were also taken but it was almost 50 years before ... small white eye-patch and bulbous forehead, was documented alive in ...
(Date:6/19/2013)... Insulin is the most potent physiological anabolic agent ... and synthesis of lipids, protein and carbohydrates, and ... system. It also plays a major role in ... glucose is metabolized and removed from the blood ... precise molecular mechanisms by which insulin regulates glucose ...
(Date:6/19/2013)... the Midwest are expected to contribute to a very ... zone," according to a University of Michigan ecologist and ... one for the Chesapeake Bay. , The Gulf forecast, ... Atmospheric Administration, calls for an oxygen-depleted, or hypoxic, region ... place it among the 10 largest on record. , ...
Breaking Biology News(10 mins):Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 3U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 4
... plant,s defences and causes disease,by sneakily disabling the plant,s ... (4 December) in Current Biology . ... causes bacterial speck disease,in tomato plants. This bacterial invasion ... cause extensive and costly damage to,tomato crops, and researchers ...
... half of a person,s body mass consisting of skeletal ... those found in the limbs can result in ... kinesiology and community health professor Kimberly Huey, past research ... may be associated with reduced expression of certain pro-inflammatory ...
... earthquakes and destructive tsunamis over the past four years is ... warns an international group of earthquake researchers in their paper ... Nature . , The first of the recent great earthquakes, ... and destructive tsunami in living memory. The cause of ...
Cached Biology News:Red alert! How disease disables tomato plant's 'intruder alarm' 2Vitamin E shows possible promise in easing chronic inflammation 2Vitamin E shows possible promise in easing chronic inflammation 3September 2007 Sumatran earthquakes research findings 2September 2007 Sumatran earthquakes research findings 3
... package is used for determining protein concentration in ... RC DC protein assay is a colorimetric assay. ... assays: 250 ml RC reagent I, 250 ml ... solution, 2 L dilute Folin reagent, and 5 ...
... SureLINK Bioconjugation Kit provides a powerful yet ... and nuceleic acids. The kit provides the ... reagents for quantifying conjugation efficiencies. It enables ... biotin and other tags with a variety ...
...
MAb to HLA, Class II-DR+DP Dry Ice: No Preservative: NaN3 Availability When Not in Inventory: 14-21 Business Days...
Biology Products: